|
|
Volumn 27, Issue 3, 2009, Pages 366-369
|
|
Beyond tumor necrosis factor: Next-generation biologic therapy for inflammatory bowel disease
|
|
Author keywords
Biologics; Crohn's disease; Ulcerative colitis
|
|
Indexed keywords
ABATACEPT;
ANTIINFLAMMATORY AGENT;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERCELLULAR ADHESION MOLECULE 1;
INTERLEUKIN 12;
INTERLEUKIN 23;
NATALIZUMAB;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR ANTIBODY;
UNCLASSIFIED DRUG;
VEDOLIZUMAB;
CELL ACTIVATION;
CONFERENCE PAPER;
CROHN DISEASE;
DRUG EFFICACY;
DRUG MECHANISM;
ENTERITIS;
HUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE;
ULCERATIVE COLITIS;
BIOLOGICAL FACTORS;
BIOLOGICAL THERAPY;
GENOME-WIDE ASSOCIATION STUDY;
HUMANS;
IMMUNITY;
INFLAMMATORY BOWEL DISEASES;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 70349919789
PISSN: 02572753
EISSN: None
Source Type: Journal
DOI: 10.1159/000228575 Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (0)
|
